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In many non-excitable and excitable cells, store-operated calcium entry (SOCE)
represents an additional pathway for calcium entry upon Ca2+ store depletion. In a
previous study, we demonstrated SOCE activity in intact mouse cardiac pacemaker
tissue, specifically from sinoatrial node (SAN) tissue. However, store content as a key
determinant of SOCE activity is difficult to measure in intact SAN tissue. Therefore,
to investigate the interaction between SOCE and store content and its role in cardiac
pacemaking, it is necessary to investigate SOCE activity in single cardiac pacemaker
cells. Furthermore, recent studies in other tissues have identified two new proteins
involved in SOCE, stromal interacting molecule (STIM), which is an ER Ca2+ sensor, and
the surface membrane channel Orai, a prototypic gene encoding for SOCE. However,
whether STIM and Orai are expressed in native pacemaker cells is still unknown. In
this current study, we examined SOCE activity in single firing pacemaker cells isolated
from mouse sinoatrial node tissue. We found a significant rise in Ca2+ entry in response
to Ca2+ store depletion. SOCE blockers reduced the amplitude and frequency of
spontaneous Ca2+ transients and reduced Ca2+ store content. We demonstrated for
the first time that STIM and Orai are expressed in pacemaker cells. After store depletion,
STIM1 redistributed to the cell periphery and showed increased co-localization with
surface membrane located Orai1, indicating a possible involvement of these proteins in
SOCE activity in native cardiac pacemaker cells. These results suggest the novel concept
that SOCE plays a functional role in regulating intracellular Ca2+ of cardiac pacemaker
cells.
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Introduction
Cardiac contraction originates in the spontaneous firing of pacemaker cells in the sinoatrial
node (SAN) of the heart. Originally it was thought that the spontaneous firing of pacemaker
cells was driven purely by voltage-dependent membrane currents (Noble, 1960) but subse-
quently it has been found that intracellular Ca2+ cycling also plays an important role (Rigg
and Terrar, 1996; Ju and Allen, 1998, 1999; Rigg et al., 2000; Lakatta et al., 2010). During each
spontaneous cycle, Ca2+ influx through L-type Ca2+ channels triggers sarcoplasmic reticulum (SR)
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Ca2+ release and produces a global Ca2+ transient. The loss of
Ca2+ from the SR causes partial depletion which recovers as the
SR Ca2+ pump (SERCA) returns Ca2+ to the SR. Ca2+ extru-
sion through the Na+/Ca2+ exchanger generates an inward cur-
rent that contributes to pacemaker diastolic depolarization.(Rigg
and Terrar, 1996; Ju and Allen, 1998, 2000; Rigg et al., 2000;
Vinogradova et al., 2000, 2006). Although controversies still exist
about the relative importance of intracellular Ca2+ cycling over
membrane currents (Lakatta and DiFrancesco, 2009; Himeno
et al., 2011), it is now generally accepted that pacemaker activity
is orchestrated by the coupled system ofmembrane ionic currents
(the “membrane clock”) and intracellular SR calcium cycling (the
“calcium clock”) (for review see, Lakatta et al., 2010).
In many non-excitable and excitable cells, store-operated cal-
cium entry (SOCE) represents an additional pathway for calcium
entry into the cell to refill the SR calcium store. SOCE is acti-
vated by the decline of Ca2+ concentration within the lumen
of the endoplasmic reticulum (ER) or SR. Activation of SOCE
produces Ca2+ influx which provides a regulatory link between
SR Ca2+ level and membrane calcium entry, thereby helping to
maintain SR calcium homeostasis (Parekh and Putney, 2005). In
a previous study, we demonstrated SOCE in an intact SAN tis-
sue preparation based on a rise of intracellular Ca2+ ([Ca2+]i)
when extracellular Ca2+ was replenished after store depletion (Ju
et al., 2007). However, SAN tissue contains pacemaker cells inter-
mingled with fibroblasts, atrial myocytes and endothelium cells,
all of which are capable of expressing SOCE (Camelliti et al.,
2004; Chen et al., 2010; Li et al., 2011). Additionally, store con-
tent as a key determinant of SOCE activity is difficult to measure
in intact SAN tissue. Therefore, to rule out possible endogenous
cell contamination and investigate store content, it is necessary to
investigate SOCE activity in single pacemaker cells.
In the present study, we examined SOCE in single firing pace-
maker cells, by measuring the changes in intracellular Ca2+ in
response to SR Ca2+ store depletion. Using two different blockers
of SOCE, SKF96365, and BTP-2, we estimated the contribution of
SOCE to pacemaker activity and the refilling of the SRCa2+ store.
The genes encoding SOCE in pacemaker cells remain to be
identified. We previously found that TRPC channel genes are
expressed in pacemaker cells isolated from mouse SAN. Because
the involvement of TRPC channels in SOCE has also been
reported in many other cell types (Clapham, 2003; Birnbaumer,
2009), this result suggests that TRPC channels could be encoding
SOCE in pacemaker cells. Ca2+ influx through TRPC channels
has also been implicated in cardiac hypertrophy (Wu et al., 2010;
Eder and Molkentin, 2011) and cardiac arrhythmias (Harada
et al., 2012). However, despite the large numbers of reports impli-
cating TRPCs as store-operated channels, whether activation
of TRPC channels requires depletion of SR Ca2+ store remain
debatable (Lewis, 2007; Birnbaumer, 2009; Putney, 2009). Accu-
mulated evidence suggests that activation of certain isoforms
of TRPC channels, especially TRPC3 and TRPC6, are directly
related to G-protein coupled receptor activation and phospho-
lipase C mediated production of diacylglycerol, referred to as
receptor-operated Ca2+ entry (ROCE) (Hofmann et al., 1999;
Onohara et al., 2006; Mohl et al., 2011). Such Ca2+ entry is
independent of SR store depletion.
In recent years, studies using genetic approaches have iden-
tified genes encoding the ER Ca2+ sensor, namely the stromal
interaction molecule (STIM) (Liou et al., 2005; Zhang et al., 2005,
also for review see Cahalan, 2009). Subsequently, the Orai fam-
ily of membrane proteins was identified as forming a prototypic
SOCE, the Ca2+ release activated Ca2+ channel (CRAC) (Feske
et al., 2006; Vig et al., 2006; Zhang et al., 2006). CRAC channels
are Ca2+-selective channels located in the cell membrane and ful-
fill the criteria for being store-operated (Feske et al., 2006; Vig
et al., 2006). In response to decreased ER Ca2+ concentration,
STIM1 translocates within the ER membrane to form discrete
surface membrane-associated aggregates where it activates Orai
channels (Lewis, 2007; Penna et al., 2008; Wang et al., 2010b). A
recent study using high resolution nuclear magnetic resonance
determined the structure of protein segments from STIM1 and
Orai1 confirmed their interaction and possible role in Orai1 acti-
vation (Stathopulos et al., 2013). There is now substantial evi-
dence that SOCE plays a key role in mediating cardiomyocyte
hypertrophy, both in vitro and in vivo, and there is growing
support for the contribution of SOCE to Ca2+ overload associ-
ated with ischemia/reperfusion injury (Collins et al., 2013). How-
ever, the expression and cellular distribution of STIM and Orai
molecules have not been determined in cardiac pacemaker cells.
In this study, we examined the expression of STIM and Orai
isoforms in pacemaker cells, their cellular localization under
physiological conditions, and redistribution after store depletion.
Materials and Methods
Single SAN Cell Isolation
Cardiac cells were harvested from male Balb/c mice (2–4 months
old) under a protocol approved by the Animal Ethics Committee
of the University of Sydney.
Single SAN cells were isolated using a modified protocol
as described previously (Liu et al., 2011). Briefly, hearts were
removed from animals and microdissection of the SAN region
was performed with constant perfusion of Tyrode solution with
1.8mmol/L Ca2+ using a dissecting microscope. A strip of tis-
sue containing the SAN region, measuring ∼0.5mm × ∼1mm,
was identified by anatomic landmarks and dissected out. The
SAN strips were cut into 3–5 smaller strips and rinsed in a
“Ca2+ free” solution containing (in mmol/L) 120NaCl, 5.4 KCl,
0.5MgCl2, 1.2 KH2PO4, 20 taurine, 11.1 glucose, 10 HEPES, 0.3
EGTA, 10 Na-Pyruvic acid, 5 Creatine, 5µmol/L Blebbistatin,
2mg/ml bovine serum albumin (BSA), pH 7.0. The rinsed SAN
tissue strips were digested in the same “Ca2+ free” solution con-
taining collagenase (229 u/ml, type II, Worthington Biochemi-
cal Corporation), elastase (1.9 u/ml) and protease (0.9 u/ml, type
XIV) for 30–40min at 35± 0.5◦C and bubbled with pure oxygen.
After enzyme digestion, the tissue was then washed and stored in
Kruftbrühe (KB) solution which contains (in mmol/L), 30KCl,
10KH2PO4, 2MgCl2, 70 L-glutamic acid, 10 HEPES, 20 taurine,
5 creatine, 0.3 EGTA, 10 Na-Pyruvic acid, 5 Creatine, 5µmol/L
Blebbistatin, 80 KOH, 11.1 glucose and 10 HEPES, with pH
adjusted to 7.2 with KOH. Single SAN cells were released by gen-
tle pipetting of the digested tissue strips. SAN cells were identified
under light microscopy by their spindle shape and small size with
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centered single nuclei. Atrial myocytes were dissociated follow-
ing the same isolation protocol while ventricular myocytes were
dissociated by the collagenase-based coronary perfusion method
as described elsewhere (Zhou et al., 2000). All chemicals were
purchased from Sigma unless otherwise specified.
Intracellular Ca2+ Recording
Isolated single mouse SAN cells were placed on laminin-coated
(20µg/ml) 35mm glass bottom petri dishes (MatTek Culture-
ware) for 20min to attach. Fluo-4-AM (FluoroPure grade, Invit-
rogen. USA) was mixed with Pluronic F-127 by sonication and
diluted to a final concentration of 5µmol/L in Tyrode solution.
This solution was used to load single pacemaker cells (20min
at room temperature). After superfusion with normal Tyrode
solution (with 1.8mmol/L Ca2+) for 20min to de-esterify Fluo-
4-AM, spontaneously beating pacemaker cells were selected for
study. A LSM 510 META confocal microscope (Carl Zeiss Inc.,
Germany) equipped with an argon laser provided excitation at
488 nm and the fluorescence signal was collected at wavelengths
of>515 nm. A heated microscope stage and a 63× /1.4 oil objec-
tive heater (PeCon GmbH, Germany) were attached to maintain
cells at 37◦C throughout the experiment. Cell shortening was
recorded by line scan mode and analyzed oﬄine with ImageJ
software (NIH, USA). Intracellular Ca2+ was recorded using
either line scan mode (xt mode) or frame mode (xy mode) with
time series. Results were recorded at Zeiss LSM scan speed 8
(3.07ms/line) and 10 s intervals exist between two consecutive
frames in frame mode. Data were analyzed with Zeiss LSM image
examiner (version 4.2, Carl Zeiss Inc., Germany) and imageJ
(NIH, USA). Global intracellular Ca2+ levels were translated
into relative fluorescence levels, F/F0, where F and F0 repre-
sent the fluorescence intensities at a given time and at minimum
resting level, respectively. Maximum change in F/F0 (in frame
mode) was calculated as the change in the peak value after Ca2+
re-admission relative to initial level before Ca2+ removal.
Reverse Trascriptase-Polymerase Chain
Reaction (RT-PCR) Analysis
Total mRNA from isolated cardiac myocytes (SAN cells, atrial
and ventricular myocytes) and spleen cells were extracted with
TRIzol (Invitrogen. USA) following manufacturer’s protocol.
Reverse transcription was carried out with 1µg total RNA using
the Superscript First-Strand Synthesis System for RT-PCR (Invit-
rogen), according to the manufacturer’s instructions. RT-PCR
was performed with Platinum Taq (Invitrogen) under the fol-
lowing conditions as described by Wissenbach et al. (2007):
one cycle 50◦C/30min; one cycle 94◦C/2min; 40–45 cycles
94◦C/15 s, 56◦C/30 s, 72◦C/30 s; one cycle 72◦C/5min. The fol-
lowing primer pairs, deduced from cDNA sequences and flank-
ing at least one intron were used: 5′ GAT CGG CCA GAG TTA
CTC C and 5′ CGA TGC ATG CGC TCG TGG (ORAI1); 5′ AA
GAA GGG AGA GAC ACA CAG and 5′ ACT CGC TGA TGG
AGT TGAG G (ORAI2); 5′ GCC AGT CAG CAC TCT CTG C
and 5′ CCA CCA GAA CAA CTT CAG CC (ORAI3); 5′ GCC
ACA GCT TGG CCT GG and 5′ GCT CCA TCA GG CTG TGG
(STIM1); 5′ TGAGGA TAC CCT GCAGTGG and 5′ CAG TCT
GCAGAC TCT CTAAG (STIM2); 5′ GCT CGAGATGTCATG
AAG G and 5′ GGC TGT ACT GCT TAA CCA GG (HPRT1).
Immunostaining and Western Blots
Immunostaining of single SAN cells was carried out using stan-
dard protocols as described previously (Liu et al., 2011). Briefly,
isolated pacemaker cells were plated onto laminin-treated slides
and allowed to settle for 30min before being fixed with 2%
paraformaldehyde (Sigma) for 5min. A subset of cells was incu-
bated with Ca2+ free Tyrode Solution with either 5µmol/L
cyclopiazonic acid (CPA) or 1µmol/L thapsigargin (TG) for
30min at room temperature before fixation. Fixed cells were
washed three times with phosphate buffer solution (PBS) over
30min, permeabilized by 0.1% Triton X-100 (Sigma) for 5min,
washed three times with PBS over 30min, and blocked with 1%
bovine serum albumin (BSA; Sigma) and 4% normal Goat serum
(invitrogen, USA) in PBS for 1–2 h before application of primary
antibody. Primary antibodies were diluted in 1% BSA and 4%
normal goat serum in PBS. Cells were incubated with primary
antibodies at an appropriate concentration (see Table 1) at 4◦C
overnight, briefly washed in PBS and then Alexa Fluo-488 goat
anti-rabbit or Alexa Fluo-561 goat anti-mouse secondary anti-
bodies (both at 1:200 dilution, Invitrogen, USA) were applied.
Cells were washed three times with PBS and then mounted with
Prolong Gold mounting media with DAPI (Invitrogen, USA)
and cover slips were sealed with nail polish. In negative control
experiments, no primary antibody was used and no labeling was
detected. Confocal images were acquired with LSM 510 META
confocal microscope (Carl Zeiss Inc., Germany) and analyzed
with LSM image examiner.
For Western blot, strips of SAN (restricted by Crista termi-
nalis, atrial septum, superior and inferior vena cava), atrium
(from left atrium wall) and ventricle (left ventricle free wall) were
freshly dissected and snap frozen in liquid nitrogen. Spleen tissue
was collected in the same way and served as positive control pro-
tein. Total protein extracts were prepared with Mammalian Cell
Lysis Kit (Sigma, Cat no: MCL1) containing RIPA buffer and pro-
tease inhibitor cocktail. Tissue samples were homogenized on ice
using a Polytron homogenizer (PT900 CL) and cleared by cen-
trifugation at 12,000 g for 10min. Protein extracts were separated
on 8% SDS-PAGE gel and transferred to a nitrocellulose mem-
brane (Whatman). The membranes were immunoblotted with
the appropriate antibodies (Table 1) following standard proce-
dures published elsewhere (Nishiyama et al., 2009). Immunoblots
were probed with antibodies against STIM1, STIM2, Orai1, and
Orai3 but not Orai2 due to lack of Orai2 mRNA expression in
cardiac cells.
Drugs
Thapsigargin (TG, 1µmol/L) and Cyclopiazonic acid (CPA,
5µmol/L) which are SR Ca2+-ATPase (SERCA) inhibitors
were used to deplete store content. The imidazole compound
SKF-96365 (1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)
propoxy]ethyl-1H-imidazole hydrochloride) has been shown
to target the STIM1-Orai1 pathway and inhibit SOCE in
cell lines (Liou et al., 2005; Huang et al., 2006). BTP-2, a
bistrifluoromethyl-pyrazole derivative, is a potent and fast-acting
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TABLE 1 | List of antibody used in the study.
Antibody Company (cat #) Clone Ab isoform Dilution staining Dilution western
ORAI1 Sigma (O8264) NA Rabbit 1:100
ORAI1 ProSci (PM-5207) NA Mouse 1:500 1:1000
ORAI3 ProSci (4117) Polyclone Rabbit 1:200 1:1000
STIM1 BD transduction 44/stim1 Mouse IgG2a 1:100 1:1000
STIM2 ProSci (4123) Polyclone Rabbit 1:400 1:1000
HCN4 Abcam (ab32675) SHG 1E5 Rat 1:800
Caveolin-3 BD transduction 26/cav-3 Mouse IgG1 1:500
SERCA2 Abcam (ab2861) 2A7-A1 Mouse IgG2a 1:500
RyR2 ABR (MA3-916) C3-33 Mouse IgG1 1:200
NCX1 Swant (R3F1) R3F1 Mouse IgG1 1:200
SOCE blocker in a number of immortal cell lines and immune
cells (He et al., 2005; Yonetoku et al., 2008). SKF-96365 and
BTP-2 (both at 10µmol/L) were used as SOCE blockers in this
study. All drugs were dissolved in DMSO as stock solution
stored at − 20◦C and diluted in Tyrode solution at working
concentration before applying to cells.
Statistical Analysis
Data were presented as means± SEM. The statistical significance
of effects was evaluated by Student’s t-test or ANOVA and a value
of P < 0.05 was considered statistically significant.
Results
SOCE Activities in Single Isolated Pacemaker
Cells
To investigate whether SOCE exists in isolated single pacemaker
cells, we studied the changes in [Ca2+]i in response to an inter-
vention protocol which involves removing extracellular Ca2+
in addition to the application of SR Ca2+-ATPase (SERCA)
inhibitor. We previously showed that this protocol caused acti-
vation of SOCE in intact mouse SAN tissue (Ju et al., 2007).
Figure 1A shows serial confocal Ca2+ images collected from an
isolated single isolated pacemaker cell undergoing the SOCE acti-
vation protocol. Under control conditions (1.8mM [Ca2+]o), the
cell exhibited spontaneous firing and regular Ca2+ transients
Figure 1A(1) (xy plot, duration 1.5 s). The cell stopped firing
when the SERCA inhibitor, cyclopiazonic acid (CPA, 5µmol/L)
was applied along with extracellular Ca2+ withdrawal from the
solution for 5min, which was associated with a significantly
reduced [Ca2+]i [Figure 1A(2)]. A marked global rise in [Ca2+]i
upon Ca2+ re-admission is demonstrated in Figure 1A(3) asso-
ciated with visible cell shortening (hypercontraction). [Ca2+]i
rapid declined after an initial transient overshoot [Figure 1A(4)].
Spontaneous Ca2+ transients associated with pacemaker firing
reappeared as [Ca2+]i gradually returned to control level after
wash off of CPA [Figure 1A(5)]. Figure 1B demonstrated the
time course of Ca2+ fluorescence intensity changes deduced
from 60 consecutively collected Ca2+ images in response to
the SOCE activation protocol. The top panel showed the tim-
ing of extracellular [Ca2+] withdrawal and readmission. A large
Ca2+ influx reached its maximum within 30 s after Ca2+ re-
admission and lasted for 1–2min (Figure 1B top trace). In con-
trast, only a small Ca2+ influx was seen in the presence of the
selective SOCE blocker BTP-2 (Yonetoku et al., 2008; Singh
et al., 2010) (Figure 1B bottom trace). We found that SKF-96365
has similar effect to BTP-2 in single pacemaker cells and the
results were similar to that previously reported in intact SAN
preparations (Ju et al., 2007). Both SOCE blockers also signifi-
cantly reduced CPA or TG -induced SOCE in single pacemaker
cells. In addition, Ca2+ influx was not seen upon reintroduc-
ing extracellular Ca2+ after removal of extracellular Ca2+ with-
out using SERCA inhibitors. Figure 1C compares the amplitude
of the [Ca2+]i rise upon Ca2+ re-admission relative to initial
levels for each treatment. These results confirm there is signif-
icant Ca2+ influx in isolated single mouse pacemaker cells in
response to a SOCE activation protocol that presumably causes
store depletion.
To confirm that the large [Ca2+]i rise was indeed associ-
ated with a store Ca2+ depletion, the store Ca2+ content was
assessed using rapid caffeine application (Figure 2). Rapid appli-
cation of caffeine causes a large and rapid rise in [Ca2+]i that
has been widely used to measure SR Ca2+ content (Bers, 1987).
Caffeine-induced Ca2+ transients were compared under con-
trol conditions [Figure 2A(i)], after 5min. of extracellular Ca2+
removal [Figure 2A(ii)], and after Ca2+ removal combined with
SERCA inhibition by TG [Figure 2A(iii)]. Three superimposed
spatially-averaged traces of caffeine-induced Ca2+ transients are
shown in Figure 2B. Note that regular spontaneous Ca2+ tran-
sients were seen only in control conditions before the applica-
tion of caffeine (black line, Figure 2B), but not in extracellular
Ca2+ free (red line) and extracellular Ca2+ free plus thapsigargin
(green line). SR Ca2+ store content indicated by caffeine induced
Ca2+ transients (quantified by maximum1F/F0) showed a small
but non-significant reduction after extracellular Ca2+ removal
(Figure 2C, n = 4 cells from 3 mice, P = 0.81) but exhibited
a large and significant fall when extracellular Ca2+ removal was
combined with SERCA inhibition (Figure 2C, n = 5 cells from
3 mice, P < 0.05). These data confirm that the combination of
extracellular Ca2+ removal and application of a SERCA blocker
cause store depletion. The large Ca2+ influx is dependent on SR
Ca2+ store content and is store-operated Ca2+ entry.
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FIGURE 1 | Characteristic store operated Ca2+ entry (SOCE)
induced in isolated pacemaker cells. (A) The left panel shows a
transmitted light image of a spontaneously firing pacemaker cell
loaded with Ca2+ indicator Fluo-4 AM. The regular spontaneous
Ca2+ transients were detected as regular fluctuations in
fluorescence intensity during a single xy frame recorded over a
period of 1.5 s, (during which there were ∼5 beats under control
condition as shown next image (1). There are five selected
fluorescent images representing intracellular Ca2+ changes under 5
different experimental conditions in the same cell; (1) control, (2)
after store depletion with 0mmol/L Ca2+ and the SERCA inhibitor
cyclopiazonic acid (CPA, 5µmol/L), (3 and 4) upon Ca2+
re-admission, and (5) wash off respectively. (B) The time course of
Ca2+ fluorescent intensity changes deduced from 60 Ca2+ images
consecutively collected at 10 s intervals. The top panel shows the
course of SOCE activation protocol, i.e., timing of extracellular
[Ca2+] withdrawal and readmission and time of application of CPA.
The bottom trace shows the intracellular Ca2+ changes in the
presence of SOCE blocker BTP-2 during the course of SOCE
activation. (C) Summary data (mean ± SEM) represents the
maximum amplitude of [Ca2+]i rise upon Ca
2+ re-admission, relative
to the initial [Ca2+]i level before Ca
2+ removal. Control experiments
were done with Ca2+ removal and re-admission only. N equals
number of cells for each group, ∗P < 0.05.
SOCE Blockers Reduce Store Content
The important physiological function of SOCE is to refill the SR
Ca2+ store (Seth et al., 2012). Thus, it would be expected that
SOCE blockers would cause decreased SR Ca store content.
To test this idea, we examined the effect of a SOCE blocker
on SR Ca2+ store content, estimated by caffeine-induced Ca2+
release (Bers, 1987). Figure 3A shows Ca2+ transients recorded
from a spontaneously beating pacemaker cell. Rapid application
of caffeine induced a large and rapid rise in [Ca2+]I under
control conditions. BTP-2 slowed the spontaneous firing rate and
reduced the amplitude of both the spontaneous Ca2+ transient
and the caffeine-induced transient. Both these observations
are clearly shown in Figure 3B which shows superimposed,
spatially-averaged records. On average BTP-2 reduced the
amplitude of the spontaneous Ca2+ transient by 24% (n = 6,
P = 0.018, Figure 3C). BTP-2 also reduced the amplitude of the
caffeine-induced Ca2+ signal—which is indicative of SR Ca2+
store content—by 22% (n = 6 cells from 4 mice, P = 0.026)
(Figure 3D). These data demonstrate SOCE inhibition reduced
store content and firing rate, which suggests that SOCE may
participate in maintaining store content and pacemaker func-
tion. To estimate how much SOCE might be involved in normal
pacemaker activity, we investigated the effect of SOCE blockers
on pacemaker firing rate. When applied to normally firing
pacemaker cells, BTP-2 reduced the firing rate by 16.0 ± 1.4%
(n = 6 cells in each group, P < 0.01 as shown in Figure 3E).
SKF-96365 also reduced pacemaker firing rate by 12.3 ± 1.8%.
The negative chronotropic effects caused by inhibition of SOCE
may indicate that SOCE might be involved in the regulation of
pacemaker activity.
Expression of STIM/Orai in Pacemaker Cells
Although we found SOCE activity in pacemaker cells as
described above, the genes encoding SOCE in pacemaker cells
remain to be identified. In recent years, Orai proteins have
emerged as new molecular candidates for the channels that
underlie the store depletion activated Ca2+ current, ICRAC
(Huang et al., 2006; Zhou et al., 2010). Before the discovery of
Frontiers in Physiology | www.frontiersin.org 5 March 2015 | Volume 6 | Article 69
Liu et al. SOCE in sinoatrial node cells
FIGURE 2 | SR Ca2+ store content measured in pacemaker cells.
(A) Representative line scan recording of [Ca2+] i and caffeine induced
Ca2+ transients, as the measurement of SR Ca2+ store content, in
SAN cells; (i) under control conditions with 1.8mmol/L Ca2+, (ii) with
removal of external Ca2+ only and (iii) with removal of Ca2+ in the
presence of TG. (B) Overlapping representative line plot traces of Ca2+
images shown in (A). The associated line colors represented [Ca2+] i
under control conditions (black), removal of external Ca2+ only (red) and
removal of Ca2+ in the presence of TG (green), respectively. (C)
Summary data (mean ± SEM) of store content indicated by maximal
rise of F/F0 measured by caffeine induced Ca
2+ release. N equals
number of cells for each group, ∗P < 0.05.
Orai genes, the TRPC channels were regarded as the most likely
candidates for SOCE. We previously found that pacemaker cells
express all TRPC isoforms, except TRPC5 (Ju et al., 2007). How-
ever, it is still debatable whether the activation of TRPC channels
is dependent on Ca2+ depletion from SR Ca2+ store (SOCE) or
is dependent on G-protein coupled receptor activation (ROCE)
(Hofmann et al., 1999). In addition, stromal interacting molecu-
lar 1 (STIM1) has been identified as the ER sensor. It is known
that activation of SOCE requires STIM1 migration and interac-
tion with other molecular components of SOCE (Lewis, 2007).
Given the importance of STIM1 and Orai, we wanted to estab-
lish their expression in pacemaker tissue. RT-PCR was performed
with mRNA extracted from isolated SAN, atrial and ventricular
myocytes, respectively. Spleen tissue was used as a positive con-
trol sample, as there is abundant expression of these genes in
immune cells. The housekeeping gene Hypoxanthine–Guanine
Phosphoribosyltransferase (HPRT) was used as an internal con-
trol. Figure 4A shows gel images of amplified PCR products.
SAN and other cardiac myocytes expressed mRNA transcripts
of STIM1, STIM2, Orai1, and Orai3, but not Orai2. In contrast,
spleen tissue expressed all STIM and Orai isoforms as reported
by others (Wissenbach et al., 2007).
Expression of STIM and Orai proteins in SAN and other
cardiac tissue were also examined by immunoblot with specific
antibodies against each isoform. Figure 4B shows bands of
STIM1, STIM2, Orai1, and Orai3 in cardiac tissues at their pre-
dicted molecular weight. The antibodies recognize proteins with
appropriate molecular weight and confirm the expression of
STIM1, STIM2, Orai1, and Orai3 in the heart tissues, including
SAN, atrial and ventricular tissue. Figure 4C shows quantitative
western blot analysis of STIM1 protein levels in spleen and heart
with heart samples normalized to spleen.
Among the different isoforms of STIM and Orai, the STIM1
and Orai1 have been considered to be the most relevant com-
ponents of SOCE (Lewis, 2007; Stathopulos et al., 2013). To
explore the possibility that STIM1 and Orai1 in pacemaker cells
are functioning in SOCE, we investigated the localization of
STIM1 and Orai1 proteins in isolated SAN cells using immuno-
histochemistry. It is known that pacemaker cells express HCN4
(hyperpolarization-activated, cyclic nucleotide-gate cation
channels, type 4) (Marionneau et al., 2005; Liu et al., 2007), a
channel carrying Ifcurrent in these cells (Herrmann et al., 2007).
Figure 4D shows that a HCN4 positive cell (green in color) iso-
lated from mouse SAN tissue also demonstrates positive labeling
of Orai1 (red in color). The distribution of Orai1 labeling is
enhanced in the surface membrane where HCN4 is also located
(yellow color showed in merged images). This result suggests
that Orai1 could form functional channels in pacemaker cells.
We found that positive HCN4 labeled cells can be also positively
labeled with anti-STIM1 antibody (data not shown). STIM1 is
an SR/ER Ca2+ sensor protein located predominantly within
the ER/SR, but also to a limited extent in the plasma membrane
(Liou et al., 2005; Wu et al., 2006). When perfused with normal
Ca2+ containing solution, the distribution of STIM1 staining was
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FIGURE 3 | The effect of BTP-2, a SOCE inhibitor on the
spontaneous firing rate, Ca2+ transient amplitude and SR Ca2+
content in pacemaker cells. (A) Confocal Ca2+ images show the
changes in firing rate and [Ca2+]i before and after BTP-2 application.
(B) The line plots deduced from images in (A) that compare
spontaneous Ca2+ transients and SR store content (caffeine induced
Ca2+ transients) before and after BTP-2 application. (C) Summary data
(mean ± SEM) represents average change of 1F/F0max of spontaneous
Ca2+ transients, SR Ca2+ content and pacemaker firing rate in control,
BTP-2, respectively. ∗P < 0.05.
mainly intracellular as showed in two isolated SAN pacemaker
cells (Figure 4E top panel). It has been reported that STIM1 can
be translocated toward the plasma membrane upon SR Ca2+
store depletion in transfected RBL cells (Liou et al., 2007). After
treating pacemaker cells with thapsigargin, we found that the
STIM1 staining was redistributed and became predominately
located at the cell membrane as shown in Figure 4E, bottom
panel.
Peripheral Redistribution of STIM1 upon
Depletion of SR Ca2+ Store
Store-dependent translocation of STIM1 appears to be a pre-
requisite for the physical interaction with Orai1, which is fol-
lowed by Orai1 activation and Ca2+ influx (Liou et al., 2007).
To further investigate whether such STIM1 translocation can
form a functional interaction with Orai1 in pacemaker cells, we
examined the localization of Orai1 and STIM1 under control
and store depleted conditions. Figure 5A shows a pacemaker
cell that was immersed in Ca2+ free solution containing thap-
sigargin before labeling with Orai1 (red) and STIM1 (green).
Orai1 labeling appears closer to the cell membrane, while STIM1
labeling also appears along the surface membrane where Orai1
is located. The colocalization of two proteins is demonstrated
by the yellow staining as showed in an enlarged panel (arrows)
[Figure 5A(ii)]. We examined two separate groups of pacemaker
cells, the control group cells that were kept in normal Tyrode
solution (Ca2+ 1.8mmol/L) whereas the store depleted cells
were kept in Ca2+ free solution containing the SERCA block-
ers CPA or TG for 30min. The translocation after store deple-
tion was quantified by dividing the diameter of cells into 4
equal regions (Figure 5B) and the ratio of two outer quartiles
(including cell membrane) to two inner quartiles (cell interior)
was calculated (Figure 5B). For Orai1, this ratio is around 2–
3, indicating substantial concentration in the cell membrane,
and does not change with store depletion (data not shown).
Conversely for STIM1, the ratio in control cells is 1.25 ± 0.12
(n = 9 cells in 1.8mM Ca2+), indicating very little con-
centration in the cell membrane, but changed significantly to
4.16 ± 0.56 (n = 9 in the presence of CPA) or 4.35 ± 1.38
(n = 9 in the presence of TG) (P < 0.05) when the store
was depleted (Figure 5C). This data shows increased peripheral
localization of STIM1 and increased colocalization of STIM1
and Orai1 upon store depletion. Under the same conditions,
images of these antibody-stained cells were analyzed for colo-
calization, utilizing the colocalization coefficient (the ratio of
colocalized STIM1 pixels to total STIM1 pixels). Colocalization
coefficients for both STIM1 increased significantly after store
depletion (Figure 5D, n ≥ 9 cells per group, P < 0.05).
Similar results were obtained for the colocalization of Orai1
with STIM1 (not shown). This increased colocalization resulting
from the peripheral redistribution of STIM1 is expected to
increase the opportunity for physical interaction between STIM1
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FIGURE 4 | Expression of STIM and Orai molecules in mouse
cardiac myocytes. (A) Total RNA was isolated from pacemaker cells
(SAN), atrial myocytes (Atrium), ventricular myocytes (Ventricle) and
spleen. Transcripts of Stim1, Stim2, Orai1, Orai2, and Orai3 in cardiac
myocytes were compared with the spleen as positive control. The
housekeeping gene Hypoxanthine–Guanine Phosphoribosyltransferase
(HPRT1) was used as an internal control. (B) Protein levels of STIM1,
STIM2, Orai1, and Orai3 were examined in total protein extracts from
SAN region (SAN), atrium (Atrium), ventricle (Ventricle) and spleen and
determined by Western Blot analysis. The nuclear protein histone was
used as loading control. (C) Bar graph showing quantitative western blot
analysis of STIM1 protein levels in spleen and heart with heart samples
normalized to spleen as 1 (n = 3 gels, P < 0.05, ANOVA). (D) Confocal
images of an isolated pacemaker cell shows expression of HCN4 (green
in color), a positive marker for pacemaker cells. The cell also positively
stained with anti-Orai1 antibody (red in color). The nucleus is stained blue
with DAPI. A merged image on the left shows the co-localization of
HCN4 and Orai1 along the surface membrane (color in yellow).
(E) Representative confocal images of an isolated pacemaker cell labeled
with STIM1 (green in color) and DAPI (blue in color). When perfused with
normal Ca2+ containing solution, positive STIM1 staining was distributed
both intracellularly and in the cell periphery as showed in the top panel.
When perfused with Ca2+-free solution containing thapsigargin, STIM1
peripheral localization was enhanced, as shown in the bottom panel.
and Orai1, resulting in activation of calcium influx through
Orai1.
Discussion
SOCE and Pacemaker Function
In the present study, we examined both the functional conse-
quences of SOCE andmolecular components of SOCE in isolated
pacemaker cells. The study strengthens our earlier identification
of SOCE in intact mouse SAN (Ju et al., 2007).
Given that pacemaker cells generate robust spontaneous fir-
ing by a combination of voltage-dependent channels and Ca2+
cycling, one might question what functional role SOCE can play
in pacemaker cells. Application of the blockers to the normally
firing pacemaker cells caused only modest reductions of the firing
rate, though the fact that they were accompanied by a reduc-
tion in store level strengthens the case for the effect arising from
blocking SOCE. Reduced SR store Ca2+ content would influ-
ence both diastolic and systolic SR Ca2+ release and hence influ-
ence pacemaker activity (Bassani et al., 1995; Vinogradova et al.,
2004, 2006). However, we could not eliminate the possible effect
of these blockers on other pacemaker currents such as voltage-
gated Ca2+ current or potassium currents, which might pre-
vent us from accurately estimating the contribution of SOCE to
pacemaker electrical activity.
From an evolutionary perspective, survival of an animal
depends critically on the activity of several small groups of pace-
maker cells. No doubt this is the reason why pacemaker cells
contain several independent pacing mechanisms so that the loss
of one through ingested toxin, injury or genetic mutation is not
necessarily lethal. The experimental data presented here demon-
strated a small change (∼15% decrease) in firing rate when SOCE
was blocked, and thus supports a possible role of SOCE in regu-
lating the firing rate under physiological conditions. Using com-
puter simulation, we recently found that an additional inward
SOCE current with a long time constant of activation (e.g.,
800ms) could lead to a small increase (∼11%) in firing rate. With
such a long activation time constant, SOCE current effectively
becomes a background current whose level changes little over
the cardiac cycle and whose magnitude depends on the mean
level of Ca2+ in the SR over the cardiac cycle, providing a cal-
cium influx regulated by mean store size (Allen et al., 2012).
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FIGURE 5 | Evidence of migration of STIM1 proteins to the cell
membrane region after store depletion. Ca2+ store was depleted by
treating cells with Ca2+ free solution plus 10µmol/L thapsigargin.
(A) The colocalization of STIM1 and Orai1 is demonstrated by
membrane staining of STIM1 in the merged image (yellow in color) and
is also indicated by white triangle arrows in the enlarged image (far
right panel). To determine the region of a cell, the confocal image of a
cell was equally divided into peripheral quarters and center quarters
across cell width, and fluorescent intensity in each quarter was plotted
against distance as demonstrated in (B). (C) Summary data of the
fluorescent intensity ratio of peripheral quarters to center quarters of
STIM1 under three conditions; control, CPA + 0 Ca2+, thapsigargin
(TG) + 0 Ca2+ (n = 9 cells in each group, P < 0.05, ANOVA). (D)
Summary data (mean ± SEM) of the colocalization coefficiency, a ratio
of STIM1 and Orai1 colocalized pixels (Colocal) over total STIM1 pixels
under three conditions. (n = 9 cells in each group, P < 0.05, ANOVA).
Background currents of this sort have been previously recog-
nized in rabbit pacemaker cells (Hagiwara et al., 1992). In this
context, it would be of interest to determine whether the back-
ground current in pacemaker cells is dependent on SR Ca2+ store
depletion.
Distribution and Localization of STIM and Orai in
Pacemaker Cells
In the present study we demonstrate that SOCE activity is
present in single pacemaker cells. We also demonstrate that
several new SOCE proteins, including STIM1, STIM2, Orai1,
and Orai3, but not Orai2, are expressed in pacemaker cells
of mouse SAN tissue. Using immunohistochemistry, we show
that while Orai1 proteins are predominantly located in the sar-
colemma, STIM1 proteins under control conditions are dis-
tributed across the cell. It has been reported that STIM activation
induces conformational changes of Orai proteins and subsequent
STIM-Orai colocalization, which forms the active store-operated
calcium channel (Lewis, 2007; Stathopulos et al., 2013). We also
found that there was a certain proportion of STIM1 and Orai1
clustered and co-localized at the periphery of pacemaker cells
in response to the store depletion. These results suggest a possi-
ble interaction between STIM1 and Orai1 and how they might
play a functional role related to SOCE. However, to further
quantify the involvement of STIM1 and Orai1 in SOCE activ-
ities in native pacemaker cells would require the use of tissue
specific/conditional knock out related genes and proteins and
then record associated changes of the amplitude of Ca2+ release
activated current (ICRAC).
While the molecular mechanism of STIM1/Orai1 activity and
their functional importance have been studied in great detail,
the functional relevance of other isoforms of STIM and Orai
still remain speculative (Hoth and Niemeyer, 2013). STIM2
and STIM1 share 60% homology in their amino acid sequence.
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Althoughwe also found the presence of STIM2, the role of STIM2
in pacemaker cells might be less significant as we did not observe
the translocation of STIM2 in response to store depletion (data
not shown).
We also found that in addition to Orai1, Orai3 was also
expressed in cardiac myocytes, including pacemaker cells, a result
consistent with a recent finding in rat ventricular myocardium
(Wolkowicz et al., 2011). In addition to forming functional SOCE
channels, STIM1 and Orai1 have been shown to interact with
many other Ca2+ handling proteins, including TRPC (Liao et al.,
2008, 2009), the L-type Ca channel (Wang et al., 2010a), the
sodium-calcium exchanger (Liu et al., 2010), the plasma mem-
brane Ca2+ ATPase (Ritchie et al., 2012), and the sarcoplasmic
reticulum Ca2+ ATPase (Lopez et al., 2008). Given that all these
potential pathways could contribute to Ca2+ handling and there-
fore pacemaker function, these offer multiple possible directions
for future research.
In our earlier work we identified that TRPC1, 3, 4, and 6 are all
expressed in pacemaker cells (Ju et al., 2007). The current study
demonstrates the presence of two of the best characterized SOCE
components, STIM1 and Orai1, in pacemaker cells and in addi-
tion demonstrates translocation of STIM1 to the sites of Orai1
on store depletion, as characterized in many other cell types.
It has been suggested that Orai and TRPC protein form com-
plexes that participate in Ca2+ entry with or without activation of
store depletion (Liao et al., 2009). Since these SOCE related pro-
teins are all expressed in the pacemaker cells, it is possible that
SOCE or related Ca2+ signaling pathways such as receptor oper-
ated Ca2+ entry (ROCE) (Hofmann et al., 1999) might contribute
to pacemaker activity under physiological or pathophysiological
conditions.
Limitations of the Current Study
A patch clamp study is needed to further establish whether SOCE
is accompanied by an inward current (Potier et al., 2009) which
directly contributes to diastolic pacemaker potential.
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